Main Subjects = Radionuclide Therapy
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer

Volume 11, Issue 1, January 2023, Pages 13-22

10.22038/aojnmb.2022.67136.1468

Kazuya Takeda; Yoshihide Kawasaki; Toru Sakayauchi; Chiaki Takahashi; Yu Katagiri; Takaya Tanabe; Yojiro Ishikawa; Keisuke Fujimoto; Masaki Kubozono; Maiko Kozumi; Keiko Abe; Kakutaro Narazaki; Shun Tasaka; Rei Umezawa; Takaya Yamamoto; Noriyoshi Takahashi; Yu Suzuki; Keita Kishida; So Omata; Akihiro Ito; Keiichi Jingu


Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates

Volume 11, Issue 1, January 2023, Pages 44-54

10.22038/aojnmb.2022.63827.1448

Harry Marquis; Kathy P Willowson; Dale L Bailey


Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol

Volume 6, Issue 2, July 2018, Pages 161-166

10.22038/aojnmb.2018.29845.1203

Raita Araki; Ryosei Nishimura; Anri Inaki; Hiroshi Wakabayashi; Yasuhito Imai; Yoshikazu Kuribayashi; Kenichi Yoshimura; Toshinori Murayama; Seigo Kinuya


Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223

Volume 6, Issue 1, January 2018, Pages 61-67

10.22038/aojnmb.2017.9896

Kaoru Maruyama; Keita Utsunomia; Takahiro Nakamoto; Shigenari Kawakita; Takashi Murota; Noboru Tanigawa


Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent

Volume 3, Issue 1, January 2015, Pages 35-42

10.7508/aojnmb.2015.01.006

samaneh zolghadri; hassan yousefnia; amir reza jalilian; mohammad ghannadi-maragheh